|
Boehringer Ingelheim GmbH - SWOT AnalysisPublished by: Datamonitor Published: Jun. 4, 2008 - 29 Pages Table of Contents
AbstractDatamonitor's Boehringer Ingelheim GmbH - SWOT Analysis company profile is the essential source for top-level company data and information. The report examines the company’s key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy.Boehringer Ingelheim (Boehringer) is a group of privately held companies. The company is engaged in the research, development, manufacture and marketing of human pharmaceuticals, biopharmaceuticals, chemicals and animal health products. The company operates in Europe, the Americas, Asia, Australasia and Africa. The company is headquartered in Ingelheim, Germany and employs about 39,800 people. The company recorded revenues of E11,584 million (approximately $15,878.6 million) during the fiscal year ended December 2007, an increase of 3.6% over 2006. The operating profit of the company was E2,100 million (approximately $2,878.5 million) during fiscal year 2007, a decrease of 1.9% over 2006. The net profit was E1,809 million (approximately $2,479.6 million) in fiscal year 2007, an increase of 5.1% over 2006. Conversion has been calculated using a 2007 average conversion rate of 1 Euro = $1.37074. (http://www.oanda.com) Scope of the Report
Get Full Details About This Report >> |
|
|||
|
About MarketResearch.com
|
||||